by Elizabeth Tolchin A new set of polymerase chain reaction (PCR) tests that aid the diagnosis of patients with suspected thrombophilia, were approved by the US Food and Drug Administration.
by Elizabeth Tolchin A new alliance provides Bristol-Myers Squibb access to 13 drug targets in the current neuroscience pipeline of Lexicon Genetics Inc. BMS will also have first crack at future neuroscience discoveries.
by Elizabeth Tolchin Under the hypothesis that 'conserved coexpression' could serve as an indicator of gene function on a genomic level, a team from Israel developed a model for comparing gene expression data and genomic sequence information across several different species at once.
by Elizabeth Tolchin Some of the trial and error in designing gene expression experiments can be avoided, yielding faster and cheaper results, thanks to a new online resource.
by Elizabeth Tolchin Cryo-electron microscopy helped determine the structure of a reovirus (respiratory enteric orphan virus) down to the 7.6-angstrom scale. The structure provides a clearer understanding of how the reovirus reproduces in cells.
by Elizabeth Tolchin Whether you toast your holiday celebrations with eggnog, champagne, or Manischewitz wine, you might expect the alcohol in these beverages to have an intoxicating effect. However, that may not always be true.
by Elizabeth Tolchin Software developer 3rd Millennium is releasing its Data Centric Knowledge Management System for biotech and pharmaceutical R&D to the public. The software, which allows the centralization and sharing of research data, can now be downloaded for free.
by Elizabeth Tolchin Boston researchers successfully created a mouse model for pancreatic cancer that approximates the behavior of the disease in humans.
by Elizabeth Tolchin A new report by market consultants Frost & Sullivan examines the US market for Alzheimer's disease drugs over the next five to seven years and finds that despite many setbacks, Alzheimer drug research and development is thriving.
Pentadot Plus, from High Throughput Genomics, enables rapid and accurate quantification of RNA expression levels in cells treated with potential new drugs.
Whole-genome human array is composed of almost 200,000 long oligo probes (60 mers), with an average coverage of 5 probes per gene. The chip designs are currently being used for gene expression analysis and comparative genomic hybridization (CGH) studies.
QIAGEN has released Version 3.0 Array-Ready Oligo Sets (AROS) for the Human and Mouse Genomes. Human AROS V3.0 contains 34,580 70 mer probes, representing 24,650 genes and 37,123 gene transcripts. Mouse AROS V3.
ProPlate integrates microscope slide based array technology and automated microplate processing. Sixteen-well module seals to any slide surface without the use of adhesive, forming leak-proof wells to isolate up to 64 microarrays per plate.
CodeLink UniSet Mouse 20K I Bioarray enables the study of gene expression across much of the mouse genome in a single experiment for drug target identification, pathway characterization, and drug effect predictions.
The Biostat® i modular bioprocess system is comprised of the Biostat i twin controller; the Biostat i interface; and either stirred tank or spinner flask culture vessels. The Biostat i twin controller allows two vessels to be controlled simultaneously.